What is the role of rapid diagnostic tests for COVID-19 IgM/IgG in the pre-operative period of cosmetic plastic surgery?
Introduction: The disease by the new coronavirus 2019 (COVID-19) emerged in China and spread globally with sustained worldwide transmission from human to human. The COVID-19 IgM/IgG rapid diagnostic tests performed at the time of hospital admission, before elective surgery, are among the most widely...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Revinter Publicações Ltda.
2021-03-01
|
| Series: | Revista Brasileira de Cirurgia Plástica |
| Subjects: | |
| Online Access: | http://www.rbcp.org.br/export-pdf/2890/en_v36n1a12.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Introduction: The disease by the new coronavirus 2019 (COVID-19) emerged in China and spread globally with sustained worldwide transmission from human to human. The COVID-19 IgM/IgG rapid diagnostic tests performed at the time of hospital admission, before elective surgery, are among the most widely used pre-operative screening methods.
Objectives: This study aims to evaluate the role of the rapid test of COVID-19 antibodies as screening in outpatients in aesthetic plastic surgery. Methods: A systematic review was carried out for studies published since December 2019, with several search terms related to the rapid antibody test for COVID-19 and SARS-CoV-2. The relevant articles were selected through the evaluation of titles and abstracts. Relevant articles have been revised. Data on the level of evidence, sensitivity, and specificity were collected.
Results: The review strategy produced 409 manuscripts. A total of 357 studies were duplicated or proved to be irrelevant to the research question. Among the remaining articles, 28 were studies without precision information, and 24 were manuscripts describing precision measures. The sensitivity varied from 18.4 to 100%; the positive predictive value between 19.7 and 100%; specificity between 94 and 100%; and the negative predictive value between 20 and 100%.
Conclusion: COVID-19 IgM / IgG rapid diagnostic tests may be inaccurate. We found no evidence to support the rapid antibody test COVID-19 or SARS-CoV-2 for outpatients in cosmetic plastic surgery. |
|---|---|
| ISSN: | 1983-5175 2177-1235 |